- Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea
-
Shin Y, Moon JH, Chin HJ, Ferrannini E, Lim S
- KMID: 2503263
- Endocrinol Metab.
- 2020 Jun;35(2):329-338.
- doi: 10.3803/EnM.2020.35.2.329
Background: We assessed the glucose-lowering efficacy of adding empagliflozin versus dose escalating existing medications in patients with uncontrolled type 2 diabetes (T2D). Methods: This was a 6-month retrospective case-control study in... -
- CITED
-
- Close
- SHARE
-
- Close
